BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Given Average Rating of “Moderate Buy” by Brokerages
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by the twenty-three brokerages that are currently covering the company, MarketBeat.com reports. Six equities research analysts have rated the stock with a hold rating and seventeen have issued a buy rating on the company. The average 1 year […]
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by the twenty-three brokerages that are currently covering the company, MarketBeat.com reports. Six equities research analysts have rated the stock with a hold rating and seventeen have issued a buy rating on the company. The average 1 year […]
